.Complying with an inadequate showing for Lykos Therapies' MDMA candidate for trauma at a latest FDA...
.AN2 Rehabs is rethinking its organization in reaction to uninspired midphase data, vowing to lay of...
.Merck & Co. is actually paying for $700 thousand ahead of time to challenge Amgen in a blood can...
.Along With Gilead Sciences on the verge of an FDA decision for its liver health condition medicatio...
.Chief executive officer David Ricks can see the firms establishing outdoors tents at basecamp behin...
.Cushion Liquidators has transformed Entero Therapies white as a slab. The financial institution got...
.Exelixis is actually quiting on its own cells variable (TF)- targeting antibody-drug conjugate afte...
.Three weeks after Roche's Genentech unit ignored an SHP2 prevention treaty, Relay Therapy has actua...
.Stoke Rehabs' Dravet syndrome medication has been actually freed from a partial grip, clearing the ...
.Intense Biotech Partner Editor Gabrielle Masson provided the 2024 class of Brutal 15 champions on t...